Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin

Randomized study of subcutaneous low mol

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

✍ Giovanni Triolo; Angelo Ferrante; Francesco Ciccia; Antonina Accardo-Palumbo; An 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## Abstract ## Objective To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus low‐dose aspirin, in women with recurrent pregnancy loss associated with antiphospholipid antibodies (aPL). ## Method